pornBLOCK

hidden_text

Online shopping for the latest electronics, fashion, phone accessories, computer electronics, toys, home&garden, home appliances, tools, home improvement and more.

The European Medicines Agency (EMA) has approved the Covid-19 vaccine developed by US biotech company Moderna for use across the EU, making it the second jab given the green light across the 27-nation bloc so far in the pandemic.

The EU drug regulator recommended granting the vaccine a conditional marketing authorization for use in people aged 18 and over, according to a statement released by the agency on Tuesday.

Emer Cooke, Executive Director of the EMA described the vaccine as “another tool to overcome the current emergency,” adding that the regulator’s work would “always be guided by the scientific evidence.”

Also on rt.com
FILE PHOTO: Healthcare workers are seen at the Expo Houten event complex in Houten, Netherlands, on January 5, 2021.
‘Sooner than expected & DIFFERENT vaccine’: Dutch PM explains Netherlands caught off guard by Pfizer jab approval amid criticism

In reaching its decision on the Moderna jab, the EMA conducted a clinical trial involving around 30,000 people, half of whom were given dummy injections, while the other half were injected with the vaccine.

The trial resulted in a 94.1 percent reduction in the number of symptomatic Covid-19 cases in people who received the vaccine, while the jab showed a 90.9 percent efficacy in participants at risk of severe Covid-19, the EMA said.

The EMA is currently conducting rolling reviews of the Covid-19 vaccine developed by Oxford University and drugmaker AstraZeneca, which is already being administered in the UK, but could still take weeks to be approved by the EU.

DETAILS TO FOLLOW



from RT World News https://ift.tt/3rYwDjI

The European Medicines Agency (EMA) has approved the Covid-19 vaccine developed by US biotech company Moderna for use across the EU, making it the second jab given the green light across the 27-nation bloc so far in the pandemic.

The EU drug regulator recommended granting the vaccine a conditional marketing authorization for use in people aged 18 and over, according to a statement released by the agency on Tuesday.

Emer Cooke, Executive Director of the EMA described the vaccine as “another tool to overcome the current emergency,” adding that the regulator’s work would “always be guided by the scientific evidence.”

Also on rt.com
FILE PHOTO: Healthcare workers are seen at the Expo Houten event complex in Houten, Netherlands, on January 5, 2021.
‘Sooner than expected & DIFFERENT vaccine’: Dutch PM explains Netherlands caught off guard by Pfizer jab approval amid criticism

In reaching its decision on the Moderna jab, the EMA conducted a clinical trial involving around 30,000 people, half of whom were given dummy injections, while the other half were injected with the vaccine.

The trial resulted in a 94.1 percent reduction in the number of symptomatic Covid-19 cases in people who received the vaccine, while the jab showed a 90.9 percent efficacy in participants at risk of severe Covid-19, the EMA said.

The EMA is currently conducting rolling reviews of the Covid-19 vaccine developed by Oxford University and drugmaker AstraZeneca, which is already being administered in the UK, but could still take weeks to be approved by the EU.

DETAILS TO FOLLOW

>